menopause

Market Access

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

News

Bayer now has approval on both sides of the Atlantic for Lynkuet, with the EU backing it for symptoms caused by both menopause and breast cancer.

News

A survey of women across six countries has found more than a third have experienced some kind of negative impact in the workplace due to menopause.

News

After a 17-year absence, a dydrogesterone-only hormone replacement therapy (HRT) formulation is available again in the UK market.

R&D

From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.

News

Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.